Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

2018 pre-MENACTRIMS workshop - Back to the future: redefining the clinical course of multiple sclerosis

2018 pre-MENACTRIMS workshop - Back to the future: redefining the clinical course of multiple sclerosis
  • Neurology
  • Multiple sclerosis
Regional workshop by Excemed
Thursday, Nov 29 2018
Dubai, United Arab Emirates

Event format

Learning Journey
Registration status
Not applicable

To register for this event, contact

For registration and accomodation please contact:
Meridiano Congress International - Senior Project Manager: Sara Guglielmini
T +39 06 88595 211 - F +39 06 88595 234 -

Registration fee


The registration fee for the whole blended programme is EUR 150,00 and includes:
• Access to the online tutorials
• Scientific sessions
• Coffee breaks and lunch
• Educational materials
• Certificate of attendance

Dinner is not included

Target audiences

This programme is designed for neurologists working in MS management coming from the MIddle East and North Africa regions who want to acquire up-to-date for improving their current practice.



Overview multiple sclerosis (MS) is living a revolutionary era due to continuous discoveries and advancements both in basic research and treatments. The expectancies of neurologists and patients have changed and there is the aspiration to preserve long term neurological functioning, to minimize complications and side effects of treatments and to guarantee a satisfactory quality of life. To fulfill such ambitious aim, healthcare providers require continuous education on the front of MS pathogenesis, mechanism of action of treatments and their short and long term undesirable consequences and on new tools to perfect diagnosis and prognosis. This blended educational activity will involve participants in a multistep learning journey focused on these themes. The activity will also include the discussion of clinical cases in order to give the opportunity to immediately apply newly acquired knowledge and discuss with international experts in the field. An

EXCEMED Learning Journey

The EXCEMED blended education approach reinforces concepts from different angles using diverse formats which reinforce the learning experience. A multistep approach is used, encompassing webbased and live activities. All activities – in-person and online – involves the full interactivity of learners. At three stages throughout the process, you will be asked to give your feedback on the learning experience through the 3 surveys. The aim of this learner-centered programme is to enhance clinical practice by exploring the ideal outcomes desired by patients, neurologists, and clinicians following MS, with individualized approaches toward attaining these goals. After completing your Learning Journey with EXCEMED, you will receive a Diploma signed by the faculty members and a final Outcomes and Feedback Report.

Learning objectives

  • Review the immunological mechanisms explaining disease progression
  • Analyze targets of innovative treatments
  • Define measures of treatment efficacy



Scientific programme



This lecture by Professor Sahraian will give an overview on the epidemiology of multiple sclerosis and explore the role of genes involved in its development. By following this activity, you will be able to:

  • Describe the main risk factors for Ms
  • Illustrate the role of genes involved in MS development and progression
  • Describe the effect of improved hygiene and urbanization on the increasing incidence of MS in Middle East


This on-line educational tool is a lecture by Professor Brueck explaining the main pathological findings in relapsing and progressive MS. With the usage of video scribing technique, you will be enabled to:

  • Describe the main pathological findings in the white matter of MS patients
  • Illustrate the new insights in grey matter pathology
  • Highlight the role of resident immune cells


Tuesday, 29 November

08.15 Registration


Chairs: R. Alroughani (Kuwait), B. Yamout (Lebanon) 

Introduction and welcome J. Inshasi (UAE) 

09.00 L1:
Revisiting the role of B and T cells subsets in MS pathogenesis P. Vermersch (France)

09.30 L2:
How to address pathogenetic B and T cells with innovative MS treatments H. Wiendl (Germany)

10.00 CC1:
From bench to bedside: clinical cases on protective and risky immune reconstitution R. Alroughani (Kuwait), P. Vermersh (France)

Coffee break


Chairs: J. Inshasi (UAE), H. Wiendl (Germany)

11.00 L3:
Diagnostic criteria for MS and NMO spectrum disorder: recent changes and new biomarkers
M.A. Sahraian (Iran)

11.30 L4:
Conventional and advanced imaging to estimate prognosis
R. Alroughani (Kuwait)

12.00 L5:
Progressive MS: determinants of worsening disability
M.F. Zakaria (Egypt)

12.30 CC2:
From theory to practice: clinical cases with challenging differential diagnosis/prognostic evaluation
M.A. Saharian (Iran), M.F. Zakaria (Egypt)

13.15 Lunch


Chairs: P. Rieckmann (Germany), M.A. Saharian (Iran)

14.15 L6:
Sequencing of disease-modifying MS therapies: a matter of efficacy
B. Yamout (Lebabon)

14. 45 L7:
Sequencing of disease-modifying MS therapies: a matter of safety
P. Vermersch (France)

15.15 L8:
Quantifying individual risks: a multidisciplinary approach
P. Rieckmann (Germany)

15.45 CC3:
From today to tomorrow: clinical cases with challenging comorbidities in the new treatment scenario
B. Yamout (Lebanon), P. Rieckmann (Germany)

16.30 Concluding remarks and end of the workshop


Continue your Learning Journey after the live intervention!


The in-depth tutorial will be a video lecture by Professor Hellwig regarding MS in pregnancy. Through the use of scribing technique, you will be able to:

  • Describe the natural history of pregnancy in MS
  • Illustrate prognostic factors predicting maternal and fetal clinical outcome
  • Explain risks of treatments regarding pregnancy in MS


This on-line course prepared by Professor Stankoff, focuses on the biological and cellular mechanisms behind remyelination and of the imaging techniques, both in use and under development, for measuring remyelination dynamics. At the end of the course, you will be able to:

  • Explain the cellular and molecular mechanisms associated with demyelination and remyelination in MS
  • Illustrate the key imaging techniques suitable for investigating demyelination and remyelination
  • Clarify future application of dynamic imaging of remyelination to MS

Raed A. Alroughani

Dasman Research Institute
Department of Medicine
Division of Neurology
Amiri Hospital
Kuwait City, Kuwait

Jihad Inshasi

Neurology Department
Rashid Hospital
Dubai, United Arab Emirates

Peter Rieckmann

Bamberg Hospital and University of Erlange
Bamberg, Germany

Mohammad Ali Sahraian

MS Research Center
Neuroscience Institute
Tehran University of Medical Sciences
Tehran, Iran

Patrick Vermersch

Department of Neurosurgery
CHU Lille
Université de Lille
Lille, France

Bassem Yamout

Professor of Clinical Neurology
Multiple Sclerosis Center Clinical Research
American University of Beirut Medical Center
Beirut, Lebanon

Heinz Wiendl

Direktor | Univ.-Prof. Prof. h.c. Dr. med.
Department für Neurologie
Klinik für Allgemeine Neurologie | University of Münster Münster | Institut für Translationale Neurologie
Albert-Schweitzer-Campus 1, Gebäude A1
Münster, 48149, Germany